Millions of eye drops recalled nationwide due to potential foreign substance
The FDA has initiated a nationwide recall of 2.5 million bottles of prednisolone acetate eye drops citing the potential presence of a foreign substance.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
Over 2.5 million bottles of prescription eye drops were recalled nationwide due to potential contamination by a foreign substance. The story concluded without further updates in the coverage.
Epilogue added 128d ago, after coverage quieted.
The brief
A recall is currently underway for over 2.5 million bottles of prednisolone acetate eye drops. The action follows warnings issued by the FDA regarding the risk of contamination from an unidentified foreign substance.
Coverage from Prevention, Eyes On Eyecare, NJ.com, MassLive, and The Hill emphasizes that the recall has been classified at the second-highest risk level. Reports suggest consumers should examine their medicine cabinets for the affected products.
Future developments will depend on further FDA guidance regarding the specific nature of the foreign substance and instructions for product disposal or return. Coverage does not yet specify which manufacturers are affected or if incidents of harm have been reported.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 131d ago.
Quick answers
How many bottles are affected by the recall?
The recall involves over 2.5 million bottles of eye drops.
Why were the eye drops recalled?
The recall was initiated due to the potential presence of a foreign substance.
What is the risk level of this recall?
The recall is classified at the second-highest risk level.
Coverage (16)
- Millions of eye drop bottles recalled over contamination concerns The Seattle Times · 130d ago
- FDA recalls eye drops over possible 'foreign substance' upi.com · 131d ago
- Millions of eye drops recalled nationwide due to potential foreign substance The Hill · 131d ago
- 2.5 million bottles of eye drops recalled nationwide, FDA warns WPTZ · 131d ago
- Eye drop recall in US affects 2.5 million bottles after contamination scare at India manufacturing plant New York Post · 131d ago
- Millions of prescription eye drops recalled nationwide over contamination concerns Fox Business · 131d ago
- 2.5 million bottles of eye drops recalled nationwide, FDA warns KCRA · 131d ago
- 2.5 Million Bottles of Eyedrops Recalled for Possible Contamination by ‘Foreign Substance’ People.com · 131d ago
- Millions of eye drops recalled nationwide. See affected products USA Today · 131d ago
- More than 2.5 million eye drop bottles recalled due to presence of a foreign substance 10TV · 131d ago
- FDA Recalls Over 2.5 Million Bottles of Eye Drops Nationwide Yahoo · 131d ago
- Over 2.5 Million Bottles of Eye Drops Recalled Nationwide, FDA Warns Prevention · 131d ago
- FDA initiates nationwide recall of 2.5M prednisolone acetate eye drops Eyes On Eyecare · 131d ago
- Check your medicine cabinet: FDA recalls 2.5M eye drops due to this ‘foreign substance’ NJ.com · 131d ago
- 2.5M bottles of eyedrops recalled for foreign substance: Second-highest risk level MassLive · 131d ago
- Millions of eye drops recalled nationwide due to potential foreign substance The Hill · 131d ago
Topics
Related trends
Roche Secures First U.S. Approval for New Breast-Cancer Pill
Roche wins FDA approval for its first U.S. oral SERD, giredestrant plus everolimus, for hormone-resistant advanced breast cancer.
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Novo Nordisk reports Wegovy injection reduced BMI and obesity rates in children as young as six in a clinical trial, expanding the drug's potential pediatric use.
The GLP-1 boom has a dark side
FDA orders new eye-risk warnings on a dozen GLP-1 drugs, including Ozempic and Zepbound, amid reports of vision-threatening events.
Millions of Americans are not taking their GLP-1 drugs as prescribed
Nearly half of U.S. GLP-1 users are altering prescribed dosing, with cost and side effects driving widespread non-adherence.
FDA rejects Summit’s ivonescimab, derailing US arrival of much-hyped PD-1xVEGF class
The United States Food and Drug Administration has rejected Summit Therapeutics and Akeso's lung cancer drug ivonescimab.
Costco-brand whipped cream recalled over potential presence of cleaning chemical
Costco has recalled its Kirkland Signature Heavy Whipped Cream over potential contamination with a cleaning chemical, pulling the product ahead of the Thanksgiving holiday.